LAMTOR2 and infection: Immunosuppressive therapy has been reported as an effective palliative treatment for GS2 until HSCT can be performed [58], while treatment with G-CSF can be useful to reduce frequency and severity of infections in MAPBP-interacting protein (MAPBPIP)-deficiency syndrome [59].